Showing posts with label Psychiatric Disorders. Show all posts
Showing posts with label Psychiatric Disorders. Show all posts
Wednesday, November 6, 2013
Kids diagnosed with ADHD needlessly taking powerful drugs - researchers
PARIS - Doctors sounded a warning Tuesday over a rise in ADHD diagnoses, saying some children may be needlessly taking powerful drugs intended to correct a poorly understood disorder.
Writing in the British Medical Journal (BMJ), the researchers noted treatment for attention-deficit/hyperactivity disorder (ADHD) had risen massively in recent years, even though its causes are unclear and drugs can have adverse effects.
ADHD is a disorder blamed for severe and frequent bouts of inattention, hyperactivity, or impulsivity. Children and young adolescents are those who are most diagnosed with it.
But some experts fear the term ADHD may "medicalise" problems related to a child's personality or maturity level, the effects of poor parenting or other home problems.
In Australia, prescriptions for the stimulant Ritalin and other ADHD drugs rose by 72 percent between 2000 and 2011, while in Britain and the Netherlands prescriptions roughly doubled between 2003 and 2008, said the paper.
According to the US National Institute of Mental Health (NIMH), nearly one in 11 American children aged 13-18 and one in 25 adults are affected by ADHD.
The analysis noted that Ritalin and other drugs were meant to be used only for "severe" ADHD symptoms, which according to research data only occur among about 14 percent of children with the condition.
Yet "about 87 percent of children diagnosed with ADHD in the US in 2010 subsequently received medication," it said, warning of "unnecessary and possibly harmful medication treatment."
The study said the main ADHD drugs could have side effects like weight change, liver damage, and dwelling on suicide. And the drugs' long-term impact, as a child moves into adulthood, remained unknown.
The study, led by Rae Thomas at the Center for Research in Evidence-Based Practice at Australia's Bond University, did not dispute the existence of ADHD as a medical condition.
It noted that children who genuinely had a severe form of it ran the risk of failure at school and of social rejection.
But it called on doctors to follow a six-step program of "watchful waiting" over 10 weeks to confirm that a child really did need help.
A separate study using lab rats suggested high, abusive doses of the chief ingredient in Ritalin stimulates a brain chemical mechanism implicated in drug addiction.
Rats were given the possibility of self-administering a dose of methylphenidate (MPH) in experiments led by Sara Jones at the Wake Forest University School of Medicine in North Caroline.
Repeated high doses of the substance released a neurochemical brake in the brain, boosting levels of the "pleasure" chemical called dopamine.
The results are important in the context of reports of widening use of MPH for a non-medical high, especially among US college students, said the paper in the journal Nature Communications on Tuesday.
"We think it (the reported abuse) is more dangerous than generally believed," Jones told AFP in a phone interview.
In rats, Ritalin caused the brain to become more sensitised to dopamine signals, which meant they did not need ever higher doses -- the opposite observed in cocaine trials.
This characteristic could make Ritalin a "gateway" drug, added to the fact that traces of it stayed in the body for a long time -- giving an added boost to a user simultaneously taking cocaine, amphetamines or other narcotics.
Jones said the rats gave themselves doses "probably between five and 10 times" the amount prescribed for children with ADHD.
"There were no effects (on the rats) from oral doses that you would typically prescribe to a child," she added. "That was comforting."
source: interaksyon.com
Wednesday, February 27, 2013
5 mental disorders have common gene problem - study
PARIS - Five major psychiatric disorders share a common problem in several faulty genes, according to the biggest study of its kind published on Thursday.
In the widest trawl yet of genetic mutations linked with mental disorders, US-led researchers looked through the DNA code of 33,332 people with autism, attention deficit-hyperactivity disorder (ADHD), bipolar disorder, major depressive disorder or schizophrenia.
Their genomes were matched against 27,888 "controls," or people who did not have these illnesses, in a bid to spot tiny changes in genes.
The five diseases have common risk factors in flaws on Chromosomes 2 and 10, and in two genes that help regulate the flow of calcium in brain cells, the investigators found.
One of the genes, called CACNA1C, has previously been fingered in bipolar disorder and schizophrenia.
The study, published in The Lancet, says the common genes are part of a much wider picture and do not by themselves explain the causes of these disorders or why their symptoms vary.
In addition, the gene samples examined by the Psychiatrics Genomics Consortium all came people from European ancestry, and the results may be different for people of different heritage, it said.
But, it added, the findings are a useful step towards better diagnosis of these illnesses.
Psychiatric disorders are difficult to categorise because symptoms can be hazy or contradictory, and little is known about their underlying cause. Environmental factors also play a part.
Previous genome comparisons have found intriguing common ground in an array of so-called auto-immune disorders, including arthritis, Crohn's disease, and psoriasis.
source: interaksyon.com
Subscribe to:
Posts (Atom)